Reduced sensitivity for EGFR T790M mutations using the Idylla EGFR Mutation Test
{{output}}
Aims: Osimertinib is a third-generation EGFR (epidermal growth factor receptor) tyrosine kinase inhibitor that is effective in non-small cell lung cancer (NSCLC) harbouring the EGFR T790M mutation. The Idylla EGFR Mutation Test i... ...
